Immunovaccine Technologies Inc. – Trademark Portfolio
Entity Type: 03
Immunovaccine Technologies Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DPX, IMV, SPAYVAC, and IMV IMMUNOVACCINE. The owner is based in Halifax, Nova Scotia.
1344 Summer Street
Suite 412
Halifax, Nova Scotia B3H 0A8 , CA
Showing of trademarks Trademarks
Trademark Classifications
Immunovaccine Technologies Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Immunovaccine Technologies Inc. have?
Immunovaccine Technologies Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 5 abandoned, 1 cancelled.
What trademark classes does Immunovaccine Technologies Inc. file in?
Immunovaccine Technologies Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Immunovaccine Technologies Inc.'s most well-known trademarks?
Immunovaccine Technologies Inc.'s registered trademark portfolio includes well-known marks such as DPX, IMV, SPAYVAC, and IMV IMMUNOVACCINE. These are among 4 currently registered trademarks in the portfolio.
What is Immunovaccine Technologies Inc.'s trademark registration success rate?
Immunovaccine Technologies Inc. has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.